IOL Chemicals Receives EDQM CEP Approval for Fenofibrate Process II
IOL Chemicals & Pharmaceuticals Ltd · Others (Uncategorized) · 25 Sept 2026, 6:42 pm
IOL Chemicals Receives EDQM CEP Approval for Fenofibrate Process II The European Directorate for the Quality of Medicines & HealthCare (EDQM) granted a Certificate of Suitability (CEP) on 24th Sep'26 to IOL Chemicals and Pharmaceuticals Limited for its API product "FENOFIBRATE – Process II". This approval comes in addition to the company's existing CEP for Fenofibrate. Process II was developed to meet specific customer requirements, strengthening IOL Chemicals' regulatory compliance and expanding its supply capabilities across regulated markets.
Original exchange filing (PDF)
More announcements from IOL Chemicals & Pharmaceuticals Ltd
- Clarification on increase in Volume · 11 Nov 2026
- The Exchange has sought clarification from IOL Chemicals & Pharmaceuticals Ltd on November 11, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. · 11 Nov 2026
- Transcript of Earning Call on the Q2 & H1 FY27 Financial Results · 05 Nov 2026
- Audio Recording of Earnings Call on the Q2 & H1 FY 27 Financial Results · 02 Nov 2026
- Investor Presentation- Q2 & H1 FY27 · 02 Nov 2026
- Press Release · 31 Oct 2026
- Outcome of the Board Meeting and submission of Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2026 · 30 Oct 2026
- Submission of Financial Results · 30 Oct 2026
